LONGITUDINAL CHANGES IN PROTEOMIC BIOMARKERS IN ALZHEIMER'S DISEASE AND CARDIOVASCULAR DISEASE

被引:0
|
作者
Theeke, Laurie [1 ]
Liu, Ying [2 ]
Wang, Silas [3 ]
Navia, R. Osvaldo [4 ]
Xiao, Danqing [5 ]
Xu, Chun [6 ]
Wang, Kesheng [7 ]
机构
[1] George Washington Univ, Washington, DC USA
[2] East Tennessee State Univ, Johnson City, TN 37614 USA
[3] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA
[4] West Virginia Univ, Morgantown, WV 26506 USA
[5] Regis Coll, Weston, MA USA
[6] Univ Texas Rio Grande Valley, Brownsville, TX USA
[7] West Virginia Univ, Sch Nursing, Hlth Sci Ctr, Morgantown, WV USA
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
igad104.37
引用
收藏
页码:1158 / 1158
页数:1
相关论文
共 50 条
  • [1] Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
    Seppala, Toni T.
    Koivisto, Anne M.
    Hartikainen, Paivi
    Helisalmi, Seppo
    Soininen, Hilkka
    Herukka, Sanna-Kaisa
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (04) : 583 - 594
  • [2] Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
    Finehout, Erin J.
    Franck, Zsofia
    Choe, Leila H.
    Relkin, Norman
    Lee, Kelvin H.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (02) : 120 - 129
  • [3] Proteomic discovery of CSF biomarkers for Alzheimer's disease
    Zhang, Jing
    Montine, Thomas J.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (05) : 497 - 497
  • [4] Serum biomarkers for Alzheimer's disease: Proteomic discovery
    German, Dwight C.
    Gurnani, Prem
    Nandi, Animesh
    Garner, Harold R.
    Fisher, Wayne
    Diaz-Arrastia, Ramon
    O'Suilleabhain, Padraig
    Rosenblatt, Kevin P.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (07) : 383 - 389
  • [5] Longitudinal changes in peripheral oxidative markers in patients with Alzheimer's disease, with or without cardiovascular disease
    Hatanaka, Hirokuni
    Hirose, Daisuke
    Hirao, Kentaro
    Shimizu, Soichiro
    Kanetaka, Hidekazu
    Hanyu, Haruo
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (06) : 1035 - 1037
  • [6] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [7] CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
    Delvenne, Aurore
    Gobom, Johan
    Schindler, Suzanne E.
    ten Kate, Mara
    Reus, Lianne M.
    Dobricic, Valerija
    Tijms, Betty M.
    Benzinger, Tammie L. S.
    Cruchaga, Carlos
    Teunissen, Charlotte E.
    Ramakers, Inez
    Martinez-Lage, Pablo
    Tainta, Mikel
    Vandenberghe, Rik
    Schaeverbeke, Jolien
    Engelborghs, Sebastiaan
    De Roeck, Ellen
    Popp, Julius
    Peyratout, Gwendoline
    Tsolaki, Magda
    Freund-Levi, Yvonne
    Lovestone, Simon
    Streffer, Johannes
    Barkhof, Frederik
    Bertram, Lars
    Blennow, Kaj
    Zetterberg, Henrik
    Visser, Pieter Jelle
    Vos, Stephanie J. B.
    [J]. ALZHEIMERS & DEMENTIA, 2024,
  • [8] Longitudinal stability of CSF biomarkers in Alzheimer's disease
    Blennow, Kaj
    Zetterberg, Henrik
    Minthon, Lennart
    Lannfelt, Lars
    Strid, Stig
    Annas, Peter
    Basun, Hans
    Andreasen, Niels
    [J]. NEUROSCIENCE LETTERS, 2007, 419 (01) : 18 - 22
  • [9] Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
    Portelius, Erik
    Brinkmalm, Gunnar
    Pannee, Josef
    Zetterberg, Henrik
    Blennow, Kaj
    Dahlen, Rahil
    Brinkmalm, Ann
    Gobom, Johan
    [J]. EXPERT REVIEW OF PROTEOMICS, 2017, 14 (11) : 1007 - 1020
  • [10] A combined proteomic and neuroimaging approach to identifying biomarkers in Alzheimer's disease
    Thambisetty, M
    Hye, A
    Foy, C
    Poppe, M
    Archer, N
    Campbell, J
    Ward, M
    Lovestone, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S303 - S304